CAS: 13451-78-0; 5-Fluorobenzo[d]Oxazole-2-Thiol

该化合物是一种氟化的七环化合物,其内含苯氧原子核心在2点被硫醇组替代,五点被氟原子组替代.这一结构具有独特的反应性,使其成为制药和农用化学合成中宝贵的中间体.氟和硫醇功能的存在,增强了其在交叉反应,核生殖替代和金属复合工艺中的效用.其电带和脱钩氟氟子子组可以提高药物设计中的代谢稳定性,而硫醇组则提供了多种衍生潜力.由于平衡的亲脂性和电子性,该化合物在生物活性分子(包括酶抑制剂和抗微生物剂)的开发方面特别有用.

结构式图片

相似化合物

153403-54-4 22876-20-6 439607-87-1

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号399-97-3 2-氨基-4-氟苯酚 | CAS号140-89-6 乙基黄原酸钾 | CAS号75-15-0 二硫化碳 | CAS号394-33-2 4-氟-2-硝基苯酚 | CAS号135533-78-7 2-氯-5-氟苯并恶唑 | CAS号93794-14-0 3-[amino-(5-flu...

合成工艺路线路线简述

  • 合成目标产物 5-Fluorobenzo[d]Oxazole-2-Thiol 主要起始原料 2-Amino-4-Fluorophenol And Potassium Ethylxanthate
  • (文献来源)合成步骤主要原料 2-Amino-4-Fluorophenol 和 Potassium Ethylxanthate
📜2-硝基-4-氟苯酚置于sulfide Carbon,铂 氢氧化钾,氢气体系中,用 乙醇,乙酸乙酯 用作溶剂,化学反应 32.0H,反应生成5-氟苯并恶唑-2-硫醇
参考文献:Benzoxazole Derivatives As Novel 5-Ht3 Receptor Partial Agonists In The Gut
标题:Benzoxazole Derivatives As Novel 5-Ht3 Receptor Partial Agonists In The Gut
摘要:A Series Of Benzoxazoles With A Nitrogen-Containing Heterocyclic Substituent At The 2-Position Was Prepared And Evaluated For 5-Ht3 Partial Agonist Activity On Isolated Guinea Pig Ileum. The Nature Of The Substituent At The 5-Position Of The Benzoxazole Ring Affected The Potency For The 5-Ht3 Receptor,And The 5-Chloro Derivatives Showed Increased Potency And Lowered Intrinsic Activity. 5-Chloro-7-Methyl-2-(4-Methyl-1-Homopiperazinyl)Benzoxazole (6V) Exhibited A High Binding Affinity In The Same Range As That Of The 5-Ht3 Antagonist Granisetron,And Its Intrinsic Activity Was 12% Of That Of 5-Ht. Compound 6V Inhibited 5-Ht-Evoked Diarrhea But Did Not Prolong The Transition Time Of Glass Beads In The Normal Distal Colon Even At A Dose Of 100 Times The Ed50 For Diarrhea Inhibition In Mice. Compounds Of This Type Are Expected To Be Effective For The Treatment Of Irritable Bowel Syndrome Without The Side Effect Of Constipation.
Doi:10.1021/jm9801004

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1007/s12032-025-03043-2
摘要:Shimpi A, Juvale K. A comprehensive review on the role of acetamido as a linker for the design and discovery of anticancer agents. Med Oncol. 2025 Sep 26;42(11):496. doi: 10.1007/s12032-025-03043-2.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知